John Rivera
description
Transcript of John Rivera
![Page 1: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/1.jpg)
John Rivera
![Page 2: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/2.jpg)
Background• Gram-positive
• Methicillin-resistant Staphylococcus aureus (MRSA)
• Nosocomial and community-acquired (CA) infections
![Page 3: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/3.jpg)
Infections
![Page 4: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/4.jpg)
Transmission/Prevention
![Page 5: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/5.jpg)
Step-wise Adaptation for ethanol-reduced susceptibility (ERS) mutants
Parent Strains(SH1000&COL)
Ethanol
![Page 6: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/6.jpg)
MIC and MBC’s
![Page 7: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/7.jpg)
MIC/MBC ResultsMIC (n =3) ± SD MBC (n =3) ± SD
_______________________________________________________________________SH1000 8.3 ± 0.6 12.0 ± 1.0SH1000-15.1 10.7 ± 0.6* 14.3 ± 1.2*SH1000-15.2 9.0 ± 0 13.0 ± 0SH1000-15.3 8.7 ± 0.6 12.7 ± 1.5 COL 6.3 ± 0.6 12.3 ± 0.6COL-14.1 8.0 ± 0* 10.7 ± 0.6*COL-14.2 8.0 ± 0* 10.3 ± 0.6*COL-14.3 8.0 ± 0* 11.3 ± 0.6COL-15.1 8.0 ± 0* 14.0 ± 1.0
COL-15.2 7.3 ± 1.0 13.7 ± 1.2COL-15.3 7.6 ± 0.6* 13.3 ± 1.5_______________________________________________________________________*p ≤ 0.05p ≤ 0.1
![Page 8: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/8.jpg)
COL & COL ERS Mutants in the Presence of 3% EtOH
3 4 5 6 7 80
0.2
0.4
0.6
0.8
1
1.2
COL
COL-14.1
COL-14.2
COL-14.3
COL + 3%
COL-14.1 + 3%
COL-14.2 + 3%
COL-14.3 + 3%
Time (h)
OD
580n
m
![Page 9: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/9.jpg)
SH1000 & SH ERS Mutants in the Presence of 3% EtOH
0 1 2 3 4 5 6 7 80
0.5
1
1.5
2
2.5
SH1000
SH1000 + 3%
SH1000-15.1
SH1000-15.1 + 3%
SH1000-15.2
SH1000-15.2 +3%
SH1000-15.3
SH1000-15.3 + 3%
Time (h)
OD
580n
m
![Page 10: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/10.jpg)
Staphyloxanthin OD425nm (n =3) ± SD
_______________________________________________________________SH1000 0.0343 ± 0SH1000-15.1 0.0103 ± 0*SH1000-15.2 0.0203 ± 0*SH1000-15.3 0.0147 ± 0* COL 0.0380 ± 0COL-14.1 0.0423 ± 0*COL-14.2 0.0457 ± 0*COL-14.3 0.0400 ± 0_______________________________________________________________*p ≤ 0.05
![Page 11: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/11.jpg)
Pulse-field gel electrophoresis
![Page 12: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/12.jpg)
Conclusion
• Using a stepwise selection ERS SH1000 and COL mutants were isolated
• ERS mutants did demonstrate higher MIC/MBCs
• Differences in ethanol susceptibility and ERS mutants suggest an ethanol stress mechanism exists in S. aureus
![Page 13: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/13.jpg)
Future Direction
• Physiological growth experiments
• Comparative-genomic sequencing (CGS)
![Page 14: John Rivera](https://reader035.fdocuments.in/reader035/viewer/2022062521/56814bf4550346895db8e51a/html5/thumbnails/14.jpg)
Acknowledgements• The whole Staph Lab• Minority Access to Research Careers
(MARC)• The National Institutes of
Health: SC1AI081425-02 (JEG), S06 GM008136-32 and (JEG, NMSU SCORE PROGRAM);R25 GM07667-30 (NMSU-MARC PROGRAM); S06 GM61222-05 (NMSU-MBRS-RISE PROGRAM);and P20RR016480 from the NM-INBRE Program of the National Center forResearch Resources. JEG also acknowledges the NMSU Undergraduate HowardHughes Medical Institute Program (52005881).